About
Tempus provides a platform combining comprehensive clinical and molecular data with artificial intelligence, primarily serving the oncology space. Their core offering is an operating system built upon the world’s largest library of such data, enhanced by recent advancements in generative AI like their clinical co-pilot, David, and digital pathology capabilities acquired through Paige. Tempus targets physicians, pharmaceutical companies, and patients seeking data-driven insights to improve cancer treatment decisions and accelerate drug development.
Stock Price
TEMData provided by TradingView & Yahoo Finance
Focus Areas
Technology Focus
healthcare ai healthcare generative ai drug discovery
Key People
E
Eric Lefkofsky Quick Stats
Total Raised $1.3B
Founded 2015
Status public
Type scaleup
Explore More
Similar Companies
Genesis Therapeutics
Burlingame, United States
87%
4 shared categories
3 shared AI types
Same country
Drug DiscoveryHealthcare AI +2
Exscientia
Oxford, United Kingdom
84%
4 shared categories
3 shared AI types
Drug DiscoveryHealthcare AI +2
Healx
Cambridge, United Kingdom
84%
4 shared categories
3 shared AI types
Healthcare AIDrug Discovery +2
Insilico Medicine
Hong Kong, Hong Kong
81%
4 shared categories
3 shared AI types
Generative AIHealthcare AI +2